These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19471115)

  • 21. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
    Guo BL; Liu Z; Aldrich WA; Lopez RD
    Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
    Kobayashi H; Tanaka Y; Yagi J; Minato N; Tanabe K
    Cancer Immunol Immunother; 2011 Aug; 60(8):1075-84. PubMed ID: 21519826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.
    Liu Z; Guo BL; Gehrs BC; Nan L; Lopez RD
    J Urol; 2005 May; 173(5):1552-6. PubMed ID: 15821484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cells.
    Nishio N; Fujita M; Tanaka Y; Maki H; Zhang R; Hirosawa T; Demachi-Okamura A; Uemura Y; Taguchi O; Takahashi Y; Kojima S; Kuzushima K
    J Immunother; 2012 Oct; 35(8):598-606. PubMed ID: 22996365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model.
    Yuasa T; Sato K; Ashihara E; Takeuchi M; Maita S; Tsuchiya N; Habuchi T; Maekawa T; Kimura S
    Cancer Immunol Immunother; 2009 Apr; 58(4):493-502. PubMed ID: 18682944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
    Zysk A; DeNichilo MO; Panagopoulos V; Zinonos I; Liapis V; Hay S; Ingman W; Ponomarev V; Atkins G; Findlay D; Zannettino A; Evdokiou A
    Cancer Lett; 2017 Feb; 386():141-150. PubMed ID: 27865798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells.
    Dokouhaki P; Schuh NW; Joe B; Allen CA; Der SD; Tsao MS; Zhang L
    Eur J Immunol; 2013 Dec; 43(12):3175-82. PubMed ID: 24019170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.
    Janssen A; Villacorta Hidalgo J; Beringer DX; van Dooremalen S; Fernando F; van Diest E; Terrizi AR; Bronsert P; Kock S; Schmitt-Gräff A; Werner M; Heise K; Follo M; Straetemans T; Sebestyen Z; Chudakov DM; Kasatskaya SA; Frenkel FE; Ravens S; Spierings E; Prinz I; Küppers R; Malkovsky M; Fisch P; Kuball J
    Cancer Immunol Res; 2020 Apr; 8(4):530-543. PubMed ID: 32019779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Cell Carcinoma-Infiltrating CD3
    Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
    Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel antibody-like TCRγδ-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma.
    Zheng J; Guo Y; Ji X; Cui L; He W
    Cancer Lett; 2013 Dec; 341(2):150-8. PubMed ID: 23920126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic β-Adrenergic Receptor Activation Augments the
    Baker FL; Bigley AB; Agha NH; Pedlar CR; O'Connor DP; Bond RA; Bollard CM; Katsanis E; Simpson RJ
    Front Immunol; 2019; 10():3082. PubMed ID: 32038628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
    Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
    Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.
    Hodgins NO; Al-Jamal WT; Wang JT; Parente-Pereira AC; Liu M; Maher J; Al-Jamal KT
    J Control Release; 2016 Nov; 241():229-241. PubMed ID: 27664328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells.
    Polito VA; Cristantielli R; Weber G; Del Bufalo F; Belardinilli T; Arnone CM; Petretto A; Antonucci L; Giorda E; Tumino N; Pitisci A; De Angelis B; Quintarelli C; Locatelli F; Caruana I
    Front Immunol; 2019; 10():2717. PubMed ID: 31824502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
    Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
    J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept.
    Almeida AR; Correia DV; Fernandes-Platzgummer A; da Silva CL; da Silva MG; Anjos DR; Silva-Santos B
    Clin Cancer Res; 2016 Dec; 22(23):5795-5804. PubMed ID: 27307596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD27(-)CD45(+) γδ T cells can be divided into two populations, CD27(-)CD45(int) and CD27(-)CD45(hi) with little proliferation potential.
    Odaira K; Kimura SN; Fujieda N; Kobayashi Y; Kambara K; Takahashi T; Izumi T; Matsushita H; Kakimi K
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1298-303. PubMed ID: 27553282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.
    Correia DV; d'Orey F; Cardoso BA; Lança T; Grosso AR; deBarros A; Martins LR; Barata JT; Silva-Santos B
    PLoS One; 2009 May; 4(5):e5657. PubMed ID: 19479075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.
    Deng X; Terunuma H; Terunuma A; Takane T; Nieda M
    Int Immunopharmacol; 2014 Oct; 22(2):486-91. PubMed ID: 25131561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.